<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "fludarabine inj VIAL">
<dose><value>25</value>
</dose>
<route><value>IV</value>
</route>
<strength><value>25 mg/mL</value>
</strength>
<frequency><value>DAILY</value>
<value>ONCE</value>
</frequency>
<instruction><value>for 5 days. Administer dose diluted in 50 mL 0.9% sodium chloride over 30 minutes.</value>
<value>for 3 days. Administer dose diluted in 100 mL 0.9% sodium chloride over 30 minutes.</value>
<value>Administer dose diluted in 100 mL 0.9% sodium chloride over 30 minutes.</value>
</instruction>
<volume><value>2 mL</value>
</volume>
<units><value>mg/m2/day</value>
</units>
<Population><value>ADULT</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Chronic Lymphocytic Leukemia, Waldenstrom&amp;apos;s Macroglobulinemia, Low Grade Lymphoma. In patients with CrCl from 30 to 70 mL/minute, decrease dose by 50%. Contraindicated in patients with CrCl less than 30 mL/minute.</value>
<value>Chronic Lymphocytic Leukemia</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3317</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary.</value>
</AHSFormularyStatus>
<AHFSName><value>Antineoplastic Agents</value>
</AHFSName>
<HighAlert><value>YES</value>
</HighAlert>
</drug>